Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 3;21(5):344. doi: 10.3892/ol.2021.12605

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Deng et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 7. — Immune-related gene signature predicts the OS of patients with BLCA. (A) Receiver operating characteristic curves evaluating accuracy of the prognostic model for predicting the OS of patients from The Cancer Genome Atlas BLCA database in 1, 3 and 5 years. (B) Risk score of each patient assessed by the prognostic model. (C) Distribution of survival status scatters for patients according to the risk scores. (D) Heatmap of gene expression levels of risk genes in the prognostic model. BLCA, bladder cancer; OS, overall survival; AUC, area under the curve; EREG, proepiregulin; PNOC, prepronociceptin; MAPT, microtubule-associated protein tau; PTGER3, prostaglandin E2 receptor EP3 subtype; EGR1, early growth response protein 1; FOSL1, FOS-related antigen 1; MICB, major histocompatibility class I polypeptide-related sequence B.